The firm looks to win new customers among US providers while also partnering with IVD companies to embed its lab data analysis tools in their instruments.
After comparing manual methods with the firm's pcr.ai tool in more than 20,000 cases, they found that the use of AI improved test accuracy and reliability.
The IMCB-A!maginostic Joint Lab of Excellence will provide AI- and machine learning-based solutions to support computational digital and multiplex pathology.
The company received an initial $1.25 million and could receive another $6.5 million to develop and commercialize a machine-learning-based sepsis detection algorithm.
As part of the initiative, the company has developed a machine learning-based solution to improve sepsis identification and decrease sepsis-related deaths.
